Enable Injections

Thank you to everyone who visited our booth at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago! Our team enjoyed meeting so many of you and demonstrating the innovative enFuse® On-Body Injector.

To learn more, please visit: https://enableinjections.com/contact-us/

In the latest episode of Progress, Potential, and Possibilities, our CCO, Matthew Huddleston shares insights with host Ira Pastor on innovation, leadership, and the future of healthcare technology.

The conversation explores the importance of collaboration, adaptability, and advancing solutions designed to support evolving patient and provider needs.

Watch the full episode here: https://www.youtube.com/watch?v=S3RKrqv2kSs

We are excited to announce CE Certification of the enFuse® on-body injector and syringe transfer system for use in combination with Aspaveli®, commercialized as ASPAVELI® enFuse® and distributed by Sobi - Swedish Orphan Biovitrum AB (publ)("Sobi") across the European Union.

This certification marks another regulatory milestone for our technology and supports our ongoing global expansion efforts to bring the enFuse system to more patients internationally.

Read more here: https://bit.ly/3PhvbK3

In a new article published in ONdrugDelivery, our SVP of Global Medical Affairs Mehul Desai, PharmD, MBA, joins authors Michael Hageman, PhD (University of Kansas) and Wei Chen, PhD (WuXi Biologics) exploring why SC conversion for ADCs is so uniquely challenging and how on-body injector technology may offer a path forward.

Learn more about these broader considerations in drug delivery and site-of-care flexibility here: https://lnkd.in/geFNxC7w

We’re excited to be at ONS Annual Congress next week in San Antonio, Texas! Visit us at Booth #504 for enFuse® demonstrations.

Also, be sure to join Haydon DuMond for his presentation, “United Kingdom Nurse and Pharmacist Preferences for On-Body Injector Technology Versus Traditional Manual Syringes in Large-Volume Subcutaneous Drug Delivery” on Thursday, May 14, 2026, 2:00–2:50 PM
Tower View Registration, Poster Pavilion, Poster Monitor 14.

If you plan to attend ONS, we look forward to connecting. Feel free to reach out to Haydon directly or visit: https://enableinjections.com/contact-us/

See you there!

The enFuse® on-body injector is designed to allow patients to remain mobile during administration, supporting greater flexibility while receiving therapy. The system is intended to deliver medication subcutaneously through a wearable device that begins administration with the push of a button, without visible needles or external tubing.

Learn more about the enFuse technology here: https://enableinjections.com/technology/

We’re pleased to announce a strategic partnership with Aptar Digital Health to develop a companion digital solution for the enFuse® On-Body Delivery System.

The solution is designed to support patients and caregivers throughout the injection process and provide tools for engagement before, during, and after administration.

Built with a flexible architecture, it is intended to support pharmaceutical partners across clinical development and commercialization.

Read more here: Lhttps://enableinjections.com/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution/

Please join us in congratulating Tim Wardle, on being named our newest enFuse® Spirit Award recipient!

Tim consistently demonstrates what it means to live Enable’s core values and has made a strong impact across the organization. When a critical regulatory initiative needed leadership at a key moment, Tim stepped in, while continuing his responsibilities as a Quality Engineer, quickly navigating complex requirements, aligning cross-functional teams, and helping drive the work forward.

His thoughtful approach, reliability, and commitment to teamwork reflect our values of Respect, Performance, Impact, Communication, and Commitment.

Tim, thank you for your dedication, collaboration, and the contributions you bring each day. We’re proud to recognize you and celebrate this well-earned achievement!

We’re looking forward to attending Hematology/Oncology Pharmacy Association (HOPA) this week in New Orleans, LA, March 25 – 27th.

Clinical pharmacists, this one is directly relevant to your practice. Be sure to join Haydon DuMond, PharmD where he will be presenting findings on how pharmacists view preparation of large-volume subcutaneous oncology drugs, comparing manual syringes vs. an on-body injector on March 26th from 5:55pm – 6:35pm.

Connect with Haydon directly to set up a meeting during the conference or visit: https://enableinjections.com/contact-us/